These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31168046)

  • 1. Cost-Effectiveness of Percutaneous Coronary Intervention Compared With Medical Therapy for Ischemic Heart Disease in Japan.
    Kodera S; Morita H; Kiyosue A; Ando J; Komuro I
    Circ J; 2019 Jun; 83(7):1498-1505. PubMed ID: 31168046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-Effectiveness of Fractional Flow Reserve-Guided Treatment for Acute Myocardial Infarction and Multivessel Disease: A Prespecified Analysis of the FRAME-AMI Randomized Clinical Trial.
    Hong D; Lee SH; Lee J; Lee H; Shin D; Kim HK; Park KH; Choo EH; Kim CJ; Kim MC; Hong YJ; Jeong MH; Ahn SG; Doh JH; Lee SY; Don Park S; Lee HJ; Kang MG; Koh JS; Cho YK; Nam CW; Choi KH; Park TK; Yang JH; Song YB; Choi SH; Gwon HC; Guallar E; Cho J; Hahn JY; Kang D; Lee JM;
    JAMA Netw Open; 2024 Jan; 7(1):e2352427. PubMed ID: 38270954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost utility of fractional flow reserve-guided percutaneous coronary intervention in multivessel coronary artery disease in Brazil.
    Stella SF; Polanczyk CA; Arvandi M; Siebert U
    Int J Qual Health Care; 2019 Nov; 31(9):676-681. PubMed ID: 30576452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment strategy modification and its implication on the medical cost of fractional flow reserve-guided percutaneous coronary intervention in Japan.
    Tanaka N; Kohsaka S; Murata T; Akasaka T; Kadota K; Uemura S; Amano T; Shiode N; Morino Y; Fujii K; Hikichi Y; Nakamura M
    J Cardiol; 2019 Jan; 73(1):38-44. PubMed ID: 30041908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness of Intravascular Imaging-Guided Complex PCI: Prespecified Analysis of RENOVATE-COMPLEX-PCI Trial.
    Hong D; Lee J; Lee H; Cho J; Guallar E; Choi KH; Lee SH; Shin D; Lee JY; Lee SJ; Lee SY; Kim SM; Yun KH; Cho JY; Kim CJ; Ahn HS; Nam CW; Yoon HJ; Park YH; Lee WS; Park TK; Yang JH; Choi SH; Gwon HC; Song YB; Hahn JY; Kang D; Lee JM;
    Circ Cardiovasc Qual Outcomes; 2024 Mar; 17(3):e010230. PubMed ID: 38477162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium Nitrite-Mediated Cardioprotection in Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: A Cost-Effectiveness Analysis.
    Jones DA; Whittaker P; Rathod KS; Richards AJ; Andiapen M; Antoniou S; Mathur A; Ahluwalia A
    J Cardiovasc Pharmacol Ther; 2019 Mar; 24(2):113-119. PubMed ID: 30081658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Cost-Effectiveness of Fractional Flow Reserve-Based Percutaneous Coronary Intervention in Stable and Unstable Angina.
    Hong D; Kim H; Lee H; Lee J; Cho J; Shin D; Lee SH; Kim HK; Choi KH; Park TK; Yang JH; Song YB; Hahn JY; Choi SH; Gwon HC; Kang D; Lee JM
    JACC Adv; 2022 Dec; 1(5):100145. PubMed ID: 38939453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis.
    Greenhalgh J; Bagust A; Boland A; Dwan K; Beale S; Fleeman N; McEntee J; Dundar Y; Richardson M; Fisher M
    Health Technol Assess; 2015 Apr; 19(29):1-130. PubMed ID: 25896573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease: Three-Year Follow-Up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation).
    Fearon WF; Nishi T; De Bruyne B; Boothroyd DB; Barbato E; Tonino P; Jüni P; Pijls NHJ; Hlatky MA;
    Circulation; 2018 Jan; 137(5):480-487. PubMed ID: 29097450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective.
    Osnabrugge RL; Magnuson EA; Serruys PW; Campos CM; Wang K; van Klaveren D; Farooq V; Abdallah MS; Li H; Vilain KA; Steyerberg EW; Morice MC; Dawkins KD; Mohr FW; Kappetein AP; Cohen DJ;
    Heart; 2015 Dec; 101(24):1980-8. PubMed ID: 26552756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of percutaneous coronary intervention for single-vessel coronary artery disease: an economic evaluation of the ORBITA trial.
    McCreanor V; Nowbar A; Rajkumar C; Barnett AG; Francis D; Graves N; Boden WE; Weintraub WS; Al-Lamee R; Parsonage WA
    BMJ Open; 2021 Feb; 11(2):e044054. PubMed ID: 33563623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of measuring fractional flow reserve to guide coronary interventions.
    Fearon WF; Yeung AC; Lee DP; Yock PG; Heidenreich PA
    Am Heart J; 2003 May; 145(5):882-7. PubMed ID: 12766748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the quality of percutaneous revascularisation in patients with multivessel disease in Australia: cost-effectiveness, public health implications, and budget impact of FFR-guided PCI.
    Siebert U; Arvandi M; Gothe RM; Bornschein B; Eccleston D; Walters DL; Rankin J; De Bruyne B; Fearon WF; Pijls NH; Harper R
    Heart Lung Circ; 2014 Jun; 23(6):527-33. PubMed ID: 24560401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease.
    Perera D; Crake T; Lee V
    Crit Pathw Cardiol; 2018 Jun; 17(2):77-82. PubMed ID: 29768315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of fractional flow reserve-guided versus angiography-guided multivessel revascularisation in ST-segment elevation myocardial infarction patients in the FLOWER-MI randomised trial.
    Le Bras A; Puymirat E; Rabetrano H; Cayla G; Simon T; Steg G; Montalescot G; Varenne O; Bonello L; Coste P; Delarche N; Georges JL; Chassaing S; Letocart V; Chatellier G; Danchin N; Durand-Zaleski I
    EuroIntervention; 2022 Jun; 18(3):235-241. PubMed ID: 35191838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and design of the Flow Evaluation to Guide Revascularization in Multivessel ST-Elevation Myocardial Infarction (FLOWER-MI) trial.
    Puymirat E; Simon T; de Bruyne B; Montalescot G; Steg G; Cayla G; Durand-Zaleski I; Blanchard D; Danchin N; Chatellier G;
    Am Heart J; 2020 Apr; 222():1-7. PubMed ID: 32000067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous coronary intervention with optimal medical therapy vs. optimal medical therapy alone for patients with stable angina pectoris.
    Gorenoi V; Schönermark MP; Hagen A
    GMS Health Technol Assess; 2011; 7():Doc07. PubMed ID: 22205918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivessel Versus Culprit Vessel-Only Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction: Insights From the TRANSLATE-ACS Observational Study.
    Ibrahim H; Sharma PK; Cohen DJ; Fonarow GC; Kaltenbach LA; Effron MB; Zettler ME; Peterson ED; Wang TY
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28982673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-Year Outcomes with PCI Guided by Fractional Flow Reserve.
    Xaplanteris P; Fournier S; Pijls NHJ; Fearon WF; Barbato E; Tonino PAL; Engstrøm T; Kääb S; Dambrink JH; Rioufol G; Toth GG; Piroth Z; Witt N; Fröbert O; Kala P; Linke A; Jagic N; Mates M; Mavromatis K; Samady H; Irimpen A; Oldroyd K; Campo G; Rothenbühler M; Jüni P; De Bruyne B;
    N Engl J Med; 2018 Jul; 379(3):250-259. PubMed ID: 29785878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction.
    Smits PC; Abdel-Wahab M; Neumann FJ; Boxma-de Klerk BM; Lunde K; Schotborgh CE; Piroth Z; Horak D; Wlodarczak A; Ong PJ; Hambrecht R; Angerås O; Richardt G; Omerovic E;
    N Engl J Med; 2017 Mar; 376(13):1234-1244. PubMed ID: 28317428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.